Ecosystem
Beta Site
Search Results
267 items found for "dendritic cell"
- LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice
Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call for GPCR
- Mechanistic exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology and molecular docking
pharmacology Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Transcriptomic analysis of human cytomegalovirus to survey the indirect effects on renal transplant recipients
Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call for GPCR
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
, Splicing Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- SSTR2 positively associates with EGFR and predicts poor prognosis in nasopharyngeal carcinoma
, proteins Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 to 2018
Malekzadeh Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody
rhabdomyosarcoma Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Clinical, pathophysiologic, genetic and therapeutic progress in Primary Bilateral Macronodular Adrenal Hyperplasia
Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call for GPCR
- Molecular docking and dynamics simulation studies uncover the host-pathogen protein-protein interactions in Penaeus vannamei and Vibrio parahaemolyticus
Afiqah-Aleng Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors
Tomoaki Tanaka Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Identification of S1PR4 as an immune modulator for favorable prognosis in HNSCC through machine learning
Molecular biology Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Involvement of Protease-Activated Receptor2 Pleckstrin Homology Binding Domain in Ovarian Cancer: Expression in Fallopian Tubes and Drug Design
receptors (PARs) Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Context-dependent ciliary regulation of hedgehog pathway repression in tissue morphogenesis
organization-especially, the role of cilia-generated effectors in mediating diverse morpho-phenotypic outcomes-is not well Mukhopadhyay Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Colorectal cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004-2018
Incidence trends Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Exploration of prognostic and treatment markers in hepatocellular carcinoma via GPCR-related genes analysis
Univariant and multivariant Cox regression analyses, as well as least absolute shrinkage and selection treatment Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non-ischaemic heart failure
Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call for GPCR
- Principles of Pharmacology in Drug Discovery II
Receptor data shows how GPCR control of cellular function goes far beyond simple second messenger production Registrants will learn: The powerful applications of new cellular assays to determine GPCR ligand behavior
- Trainee Symposium I
interests in research are primarily directed towards methods that study GPCRs and GPCR signaling, as well In my current research project I use iPSC-derived cardiac fibroblasts to examine cellular signaling in protein-coupled receptors (GPCRs) ligands for the treatment of chronic pain but also in deciphering cellular
- Ep 70 with Dr. Stephen Ferguson
Stephen Ferguson is a Professor in the Department of Cellular and Molecular Medicine at the University
- Ep 135 with Dr. Katarzyna Marcinkiewicz
During her postdoctoral training at New York University School of Medicine, her research focused on cellular
- A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer’s Mice
Stephen Ferguson’s laboratory in the Departments of Cellular & Molecular Medicine and Neuroscience at
- Ep 45 with Dr Ralf Jockers
the CNRS, is chair of IUPHAR « Melatonin receptor » sub-committee, Editor-in-Chief of « Frontiers in Cellular
- Ep 117 with Dr. Pierre Eftekhari
and biologist , with more than 25 years of experience in drug development. have been engaged in GPCR cellular
- Regulation and role of mitochondria delta opioid receptors
papers where he used various approaches to describe the role of opioid receptors in pain and anagesia as well as to study the mechanisms involved in the cellular trafficking of the delta opioid receptor.
- GPCR Retreat 2023 - Part II
Stephen Ferguson’s laboratory in the Departments of Cellular & Molecular Medicine and Neuroscience at
- Ep 141 with Dr Tobi Langenhan
This entails the deciphering of cellular and organ functions, which require individual adhesion GPCRs
- Ep 92 with Dr. Stephane Angers
Angers was named Director of the Donnelly Centre of Cellular and Biomolecular Research at the University
- Ep 02 with Dr. Terry Hébert
Today he and his team are working on understanding receptor signaling in specialized cellular environments
